Streptococci are Gram-positive cocci that play multiple roles in our daily lives. They can both cause disease and serve as beneficial commensals in our ecosystems. This article will explore the different species of Streptococcus and the delicate balance between their pathogenicity and commensal functions.
Streptococci are spherical bacteria that form a unique chain structure. This is due to the fact that their cells divide along a single axis. In contrast to staphylococci, which form irregular grape-like aggregates, this arrangement of streptococci enables them to exhibit specific biological functions in the body and in the external environment. Most of them are oxidase negative and catalytic enzyme negative, and are facultative anaerobic, that is, they can grow in an aerobic or anaerobic environment.
There are many species of Streptococcus, some of which are closely associated with a variety of human illnesses, including strep throat, bacterial pneumonia, meningitis, and more. However, not all streptococci are pathogenic; in fact, there are many species that are common commensal bacteria that play an important role in maintaining the health of the oral and intestinal microbiota.
Whether pathogenic or commensal, the role of streptococci illustrates the close connection between bacteria and human health.
Streptococci are divided into three categories based on their hemolytic properties: alpha hemolysis, beta hemolysis and gamma hemolysis. Alpha-hemolytic bacteria can cause partial destruction of red blood cells, causing a green color on blood agar. Beta-hemolytic bacteria such as Streptococcus group A (Streptococcus pyogenes) and group B (Streptococcus agalactiae) will cause complete destruction of red blood cells, forming a transparent area. γ-hemolytic bacteria do not cause any hemolytic reaction.
Among them, Streptococcus group A (GAS) usually causes a large number of infections, including pharyngitis and skin infections, and may even cause serious complications such as acute rheumatic fever and tubulitis. It is estimated that GAS causes more than 500,000 deaths each year and is one of the major pathogens worldwide.
The pathogenicity of Streptococcus lies not only in direct infection, but also in triggering abnormal reactions of the immune system, further damaging the human body
The other side of strep is their role in food preparation, such as in the production of Swiss cheese, where certain streptococci are essential. In addition, they are part of the mouth and digestive system, helping us digest food and coexisting with other microorganisms to maintain ecological balance.
Clinically, streptococcal infection can usually be diagnosed with a simple test, the most commonly used test being a rapid throat test. The main drugs used to treat strep infections are antibiotics from the penicillin family, such as penicillin or amoxicillin, which block bacterial cell wall synthesis. For patients allergic to penicillin, alternative drugs such as clindamycin may be used.
With the advancement of medical technology, research on Streptococcus is also deepening. The development of genomics has led to a more comprehensive understanding of streptococci, including their evolutionary relationships and biological properties. Therefore, the future challenge lies in developing effective preventive and therapeutic strategies to target the pathogenicity of streptococci while maintaining their beneficial role in the ecosystem.
In bridging the topic of pathogenicity and symbiosis, can we find ways to enable our microbial partners to coexist with us without posing a threat?